Engineered Probiotics Eliminate Brain Cancer by Recruiting Immune Memory in Mice

Glioblastoma represents the most aggressive form of brain cancer, with patients typically surviving less than 15 months due to the tumor's ability to evade immune detection and resist treatment. This groundbreaking study demonstrates how engineered probiotics could revolutionize cancer treatment by harnessing the body's natural defense systems.

Researchers at Shandong University engineered beneficial bacteria to recruit CAR (Chimeric Antigen Receptor) macrophages - specialized immune cells designed to hunt cancer. The team tested this approach in mouse models of heterogeneous glioblastoma, which mimics the complex, varied nature of human brain tumors.

The engineered probiotics successfully eliminated tumors by establishing immune memory, meaning the immune system learned to recognize and destroy cancer cells even after initial treatment ended. This memory effect prevented tumor recurrence, addressing a major challenge in cancer therapy where remaining cells often regrow into new tumors.

For longevity and health optimization, this research suggests the microbiome could serve as a programmable platform for enhancing immune function against cancer and other diseases. The approach combines two cutting-edge fields: microbiome engineering and immunotherapy, potentially offering safer alternatives to traditional chemotherapy and radiation.

However, this remains early-stage research conducted only in mice. Human trials would need to demonstrate safety and efficacy before clinical application. The complexity of human brain tumors and immune systems may present additional challenges not captured in animal models.